NOX4 and cardiac hypertrophy: Specifically, NOX4 overexpression exacerbated left ventricular (LV) contractile dysfunction and cardiac hypertrophy following TAC [4,49], and induced adverse cardiac remodeling to phenylephrine [60] (Table 3).